Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT04996628

Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic Pancreatitis

Led by University of Pittsburgh · Updated on 2025-12-22

150

Participants Needed

3

Research Sites

234 weeks

Total Duration

On this page

Sponsors

U

University of Pittsburgh

Lead Sponsor

N

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Abdominal pain in chronic pancreatitis (CP) affects up to 90% of patients during the course of their disease, and response to currently available therapies is suboptimal and unpredictable. The proposed clinical trial will evaluate the predictive capability of Pancreatic Quantitative Sensory Testing (P-QST) - a novel assessment of neurosensory phenotyping- for improvement in pain in patients with CP who are undergoing medically-indicated invasive treatment with endoscopic therapy or surgery.

CONDITIONS

Official Title

Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic Pancreatitis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients 18 years of age or older with definite chronic pancreatitis undergoing decompressive invasive treatments (endoscopic therapy or surgery) to relieve main pancreatic duct obstruction due to stones and/or stricture for pain management
  • Endoscopic therapy includes ERCP with pancreatic duct stone removal, stent placement, and/or stricture dilation, with or without intraductal lithotripsy or Extracorporeal Shock Wave Lithotripsy (ESWL)
  • Surgery includes drainage procedures such as Frey and Puestow operations
Not Eligible

You will not qualify if you...

  • Patients with chronic pain from conditions other than chronic pancreatitis
  • Patients under 18 years of age
  • Patients who have had endoscopic therapy within the past 12 months
  • Patients who have undergone prior pancreatic surgery
  • Patients who have planned resective surgical procedures (e.g., Whipple procedure, Total Pancreatectomy)
  • Patients with peripheral sensory deficits
  • Patients known to be pregnant at the time of study screening
  • Women who become pregnant during the study cannot continue P-QST testing

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Indiana University Medical Center

Indianapolis, Indiana, United States, 46202

Actively Recruiting

2

Johns Hopkins Medical Institutions

Baltimore, Maryland, United States, 21287

Actively Recruiting

3

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States, 15213

Actively Recruiting

Loading map...

Research Team

A

Anna Evans Phillips, MD, MS

CONTACT

A

Apsara Mishra

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here